Morpholino

MO3-psen1

ID
ZDB-MRPHLNO-080421-1
Name
MO3-psen1
Previous Names
  • MoPS1TIn (1)
  • MoPsen1B (1)
  • MoTln (1)
Target
Sequence
5' - ACTAAATCAGCCATCGGAACTGTGA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO3-psen1
Phenotype
Phenotype resulting from MO3-psen1
Phenotype Fish Figures
ball increased size, abnormal WT + MO3-psen1 Fig. 2 from Nornes et al., 2008
brain hydrocephalic, abnormal WT + MO3-psen1 Fig. 2text only from Nornes et al., 2008
extension aplastic, abnormal WT + MO3-psen1 Fig. 2 from Nornes et al., 2008
extension decreased size, abnormal WT + MO3-psen1 text only from Nornes et al., 2008
fourth ventricle increased size, abnormal WT + MO3-psen1 Fig. 1 from Nornes et al., 2009
hindbrain hydrocephalic, abnormal WT + MO3-psen1 Fig. 1 from Nornes et al., 2009
melanocyte decreased amount, abnormal WT + MO3-psen1 Fig. 1 from Nornes et al., 2009
Fig. 2 from Nornes et al., 2008
melanocyte decreased size, abnormal WT + MO3-psen1 Fig. 2 from Nornes et al., 2008
melanocyte spatial pattern, abnormal WT + MO3-psen1 Fig. 2 from Nornes et al., 2009
midbrain hydrocephalic, abnormal WT + MO3-psen1 Fig. 1 from Nornes et al., 2009
neural crest cell decreased amount, abnormal WT + MO3-psen1 Fig. 4 from Nornes et al., 2009
neural crest cell development disrupted, abnormal WT + MO3-psen1 Fig. 4 from Nornes et al., 2009
neuron increased amount, abnormal WT + MO3-psen1 Fig. 4 from Nornes et al., 2009
post-vent region melanocyte decreased amount, abnormal WT + MO3-psen1 Fig. 3 from Nornes et al., 2009
somitogenesis disrupted, abnormal WT + MO3-psen1 text only from Nornes et al., 2009
spinal cord decreased thickness, abnormal WT + MO3-psen1 Fig. 2 from Nornes et al., 2008
tectal ventricle increased size, abnormal WT + MO3-psen1 Fig. 1 from Nornes et al., 2009
trunk melanocyte decreased amount, abnormal WT + MO3-psen1 Fig. 2Fig. 3 from Nornes et al., 2009
whole organism decreased size, abnormal WT + MO3-psen1 Fig. 1 from Nornes et al., 2009
Phenotype of all Fish created by or utilizing MO3-psen1
Phenotype Fish Conditions Figures
fourth ventricle increased size, abnormal WT + MO3-psen1 standard conditions Fig. 1 from Nornes et al., 2009
melanocyte decreased amount, abnormal WT + MO3-psen1 standard conditions Fig. 1 from Nornes et al., 2009
Fig. 2 from Nornes et al., 2008
neural crest cell development disrupted, abnormal WT + MO3-psen1 standard conditions Fig. 4 from Nornes et al., 2009
brain hydrocephalic, abnormal WT + MO3-psen1 standard conditions Fig. 2text only from Nornes et al., 2008
post-vent region melanocyte decreased amount, abnormal WT + MO3-psen1 standard conditions Fig. 3 from Nornes et al., 2009
trunk melanocyte decreased amount, abnormal WT + MO3-psen1 standard conditions Fig. 2Fig. 3 from Nornes et al., 2009
melanocyte decreased size, abnormal WT + MO3-psen1 standard conditions Fig. 2 from Nornes et al., 2008
somitogenesis disrupted, abnormal WT + MO3-psen1 standard conditions text only from Nornes et al., 2009
neural crest cell decreased amount, abnormal WT + MO3-psen1 standard conditions Fig. 4 from Nornes et al., 2009
melanocyte spatial pattern, abnormal WT + MO3-psen1 standard conditions Fig. 2 from Nornes et al., 2009
neuron increased amount, abnormal WT + MO3-psen1 standard conditions Fig. 4 from Nornes et al., 2009
hindbrain hydrocephalic, abnormal WT + MO3-psen1 standard conditions Fig. 1 from Nornes et al., 2009
extension decreased size, abnormal WT + MO3-psen1 standard conditions text only from Nornes et al., 2008
extension aplastic, abnormal WT + MO3-psen1 standard conditions Fig. 2 from Nornes et al., 2008
ball increased size, abnormal WT + MO3-psen1 standard conditions Fig. 2 from Nornes et al., 2008
spinal cord decreased thickness, abnormal WT + MO3-psen1 standard conditions Fig. 2 from Nornes et al., 2008
tectal ventricle increased size, abnormal WT + MO3-psen1 standard conditions Fig. 1 from Nornes et al., 2009
whole organism decreased size, abnormal WT + MO3-psen1 standard conditions Fig. 1 from Nornes et al., 2009
midbrain hydrocephalic, abnormal WT + MO3-psen1 standard conditions Fig. 1 from Nornes et al., 2009
melanocyte decreased amount, abnormal WT + MO2-psen2 + MO3-psen1 standard conditions Fig. 1 from Nornes et al., 2009
midbrain hydrocephalic, abnormal WT + MO2-psen2 + MO3-psen1 standard conditions Fig. 1 from Nornes et al., 2009
trunk melanocyte decreased amount, abnormal WT + MO2-psen2 + MO3-psen1 standard conditions Fig. 2 from Nornes et al., 2009
fourth ventricle increased size, abnormal WT + MO2-psen2 + MO3-psen1 standard conditions Fig. 1 from Nornes et al., 2009
whole organism decreased size, abnormal WT + MO2-psen2 + MO3-psen1 standard conditions Fig. 1 from Nornes et al., 2009
hindbrain hydrocephalic, abnormal WT + MO2-psen2 + MO3-psen1 standard conditions Fig. 1 from Nornes et al., 2009
melanocyte spatial pattern, abnormal WT + MO2-psen2 + MO3-psen1 standard conditions Fig. 2 from Nornes et al., 2009
tectal ventricle increased size, abnormal WT + MO2-psen2 + MO3-psen1 standard conditions Fig. 1 from Nornes et al., 2009
Citations